Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Actualites Odonto-Stomatologiques
|
January 1, 1981
[Various facial and orodental pains]
C Thurel, J P Cavaillon, P Treyssac, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 31, 1995
Surfactant associated protein A determination using a chemiluminescence system--application to tracheal aspirates from newborns
J Taïeb, J Francoual, J F Magny, et al.
Gastroenterologie Clinique Et Biologique
|
October 8, 1998
[Hepatocellular carcinoma complicating agenesis of the portal vein]
J Taïeb, L Castera, V Boige, et al.
Human Reproduction (Oxford, England)
|
April 30, 1999
Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation
C Rongières-Bertrand, F Olivennes, C Righini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma
E Mitry, J Taïeb, P Artru, et al.
Bulletin Du Cancer
|
September 4, 2008
[Systematic review: value of perioperative chemotherapy in the management of resectable rectal adenocarcinoma (brief report)]
Y Bécouarn, S Guillo, P Artru, et al.
British Journal of Cancer
|
July 23, 2013
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer
N Chaput, M Svrcek, A Aupérin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2002
Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
J Taïeb, P Artru, B Baujat, et al.
Physical Review Letters
|
June 6, 2003
Experimental indications for the response of the spectators to the participant blast
M V Ricciardi, T Enqvist, J Pereira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study
J Taïeb, T Lecomte, T Aparicio, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Actualites Odonto-Stomatologiques
|
January 1, 1981
[Various facial and orodental pains]
C Thurel, J P Cavaillon, P Treyssac, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 31, 1995
Surfactant associated protein A determination using a chemiluminescence system--application to tracheal aspirates from newborns
J Taïeb, J Francoual, J F Magny, et al.
Gastroenterologie Clinique Et Biologique
|
October 8, 1998
[Hepatocellular carcinoma complicating agenesis of the portal vein]
J Taïeb, L Castera, V Boige, et al.
Human Reproduction (Oxford, England)
|
April 30, 1999
Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation
C Rongières-Bertrand, F Olivennes, C Righini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma
E Mitry, J Taïeb, P Artru, et al.
Bulletin Du Cancer
|
September 4, 2008
[Systematic review: value of perioperative chemotherapy in the management of resectable rectal adenocarcinoma (brief report)]
Y Bécouarn, S Guillo, P Artru, et al.
British Journal of Cancer
|
July 23, 2013
Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer
N Chaput, M Svrcek, A Aupérin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2002
Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
J Taïeb, P Artru, B Baujat, et al.
Physical Review Letters
|
June 6, 2003
Experimental indications for the response of the spectators to the participant blast
M V Ricciardi, T Enqvist, J Pereira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2006
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study
J Taïeb, T Lecomte, T Aparicio, et al.
Page
of 4